Molusco contagioso del párpado: manifestación cutánea de inmunosupresión / Eyelid molluscum contagiosum: Cutaneous manifestation of immunosuppression

Resumen El molusco contagioso es una infección viral cutánea, usualmente benigna y autolimitada, causada por un virus del género Molluscipoxvirus. Es más frecuente en niños, adultos jóvenes sexualmente activos e inmunosuprimidos. La lesión clínica característica es una pápula umbilicada eucrómica o de tono perlado, que se disemina rápidamente y puede afectar cualquier superficie muco-cutánea, aunque la localización en los párpados es atípica. Se presentan dos casos de pacientes jóvenes inmunosuprimidos, con moluscos contagiosos palpebrales, en quienes el diagnóstico clínico inicial fue incorrecto. Se enfatiza la importancia de diagnosti car oportunamente las lesiones papulares que afectan la piel del párpado ya que la presencia de molusco contagioso en esta zona se considera una manifestación cutánea de inmunosupresión.

Abstract Molluscum contagiosum is a cutaneous viral infection, usually benign and self-limited, caused by the molluscum contagiosum virus, of the genus Molluscipoxvirus. It is more common in pediatric population, sexually active young people and immunosuppressed patients. Clinical presentation is characterized by umbilicated white to flesh-colored or pearly papules, which rapidly spread and can affect any muco-cutaneous membrane. Although the eyelid presentation is atypical, we herein present two young, immunosuppressed patients, with diagnosis of palpebral molluscum contagiosum, in which the initial clinical diagnosis was wrong. We emphasize the importance in making a timely diagnosis of papular lesions localized on the eyelids and the correlation of these lesions as a cutaneous manifestation of immunosuppression.

Early HHV-6 replication is associated with morbidity non-related to CMV infection after kidney transplantation

Human herpesvirus type 6-(HHV-6) has been associated with morbidity after liver transplantation. OBJECTIVE: The aim of this study was to determine the HHV-6 seroprevalence among donor-recipient pairs, analyze the incidence of early active infection, its clinical manifestation, interaction with CMV, and the related morbidity in the first year after kidney transplantation. METHODS: 46 donor-recipient pairs had IgG evaluated by ELISA before transplantation: HHV-6(Pambio - USA) and CMV-(Roche - USA). A frozen whole blood sample collected weekly (from the 1st to the 6th week) was retrospectively tested for HHV-6 viral load (VL) determination by real time quantitative PCR (qPCR, Nanogen - Italy). Patients were preemptively surveyed for CMV by pp65 antigenemia (Ag, APAAP, immunohistochemistry, Biotest - Germany) from the 4th to the 12th week after transplantation. Active infection was defined as qPCR-HHV6+ (viral-load/mL-VL) and Ag+ (+cells/100.000 granulocytes), for HHV-6 and CMV, respectively. DCMV was defined as simultaneous positive antigenemia and suggestive signs/symptoms. Concerning +qPCR-HHV6, associated factors, clinical manifestation, interaction with CMV and morbidity were searched. RESULTS: Pre-transplant HHV-6 seroprevalence was significantly higher among kidney recipients compared to their donors (82.6x54.8%; p = 0.005 [3.9 (1.4-10.4)]). Active infection by this virus occurred in 26.1% (12/46), with no association with previous IgG (p = 0.412). Median VL was 125 copies/mL (53-11.264), and the median Ag was 21 +cells (2-740). There was no association between HHV-6 and CMV activation after transplantation (p = 0.441), neither concerning DCMV (p = 0.596). Median highest Ag+ and days of ganciclovir treatment were similar between qPCR-HHV6 + or - (p = 0.206 and p = 0.124, respectively). qPCR-HHV6+ was associated with higher incidence of bacterial (p = 0.009) and fungal (p = 0.001) infections, and higher number (p = 0.001) of hospital admission and longer duration of hospitalization over the first 6 and 12 months post-transplantation (p = 0.033 and p = 0.001). CONCLUSION: Latent HHV-6 infection is more common among recipients than donors before transplantation. Early active infection by this pathogen after transplantation does not increase DCMV incidence or severity during the first 3 months of follow-up. However, early HHV-6 replication is associated with other infections and hospitalizations in the first year.

The correlation and clinical significance of HBV infection makers / 中国基层医药

Objective To explore the internal relations of HBV markers and its clinical significance.Methods HBV Pre S1-Ag、HBV-M(HBsAg、HBsAb、HBeAg、HBeAb、HBcAb)and HBV DNA of 106 patients were detected by ELISA and FQ-PCR respectively.Results The total positive rates of Pre-S1 antigen and HBV DNA in 106 cases were 81.1%and 84.9%respectively.In41 HBeAg-positive cases.Pre S1-Ag and HBV DNA detection rate was 95.1%.90.2%.And HBeAg-negative 2 groups Pre S1-Ag and HBV DNA detection rate was also higher.Conclusion HBV Per S1-Ag Was a very valuable serum marker in terms of direct HBV replication alone can not HBeAg-positive to determine whether the replication of the virus.

Gene quasispecies analysis of transfusion transmitted virus DNA in two patients with transfusion transmitted virus infection / 中国医师杂志

Objective To investigate gene variation and the relationship between gene variation and pathogenicity of transfusion transmitted virus(TTV).Methods The TTV DNA in the serum sample from a blood donor(BD) and a chronic non-A-G severe hepatitis(CSH) patient with TTV infection was amplified by using PCR.The purified PCR product was cloned and 10 clones from each case were sequenced.The sequences were compared among different clones and analyzed by Phylogentic tree.Results There were two different TTV strains in the BD and seven different TTV strains in the chronic non-A-G severe hepatitis patient.The TTV clones in the BD were of G1a subtype and those of the CSH were of G1a and G1b subtype.Conclusion Gene variant of TTV was much more complicated in the CSH patients than that in the BD ones.

Is the so-called "immune" reaction to smallpox vaccination a misnomer?

1. Vaccine virus, either potent or heated, can produce reactions which may be described as immediate or immune2. The morphologic characteristics of the reactions are the same in both potent and heated vaccines; 3. While those produced by heated vaccine tend to regress beginning the 3rd day and completely disappear by the 6th day after vaccination, those produced by potent vaccine continue to develop to their maximum intensity until about the 10th day; and4. Areolo-vesicular reactions with cloudy fluid inside the vesicles are also produced by heated inactivated virus as early as 24 hours after vaccination. (Conclusion)

Vigilance against smallpox --- a constant need

The threat of smallpox to the Philippines is real. It is evident that quarantine measures alone, no matter how strictly implemented, cannot provide any absolute protection against the chances of a smallpox flare-up in this country. Nothing short of isolating all incoming passengers for 14 days can do this. Even so, such a drastic action will not take care of those who sneak into our shores from infected areas. It may be restating the obvious, but it can never be emphasized enough that only the continuous maintenance of an immune population can constitute the stronger bulwark against such a scourge. And, as I have already mentioned, immunity should cover at least 80% of the population. The big question arises: How adequately can we come up to such levels of protection for our country? The answer to this depends upon the full cooperation not only of those in the public health service but also of all medical men together with an enlightened public. (Conclusion)